Tags

Type your tag names separated by a space and hit enter

Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex.
J Virol. 2020 May 04; 94(10)JV

Abstract

For cell entry, vaccinia virus requires fusion with the host membrane via a viral fusion complex of 11 proteins, but the mechanism remains unclear. It was shown previously that the viral proteins A56 and K2 are expressed on infected cells to prevent superinfection by extracellular vaccinia virus through binding to two components of the viral fusion complex (G9 and A16), thereby inhibiting membrane fusion. To investigate how the A56/K2 complex inhibits membrane fusion, we performed experimental evolutionary analyses by repeatedly passaging vaccinia virus in HeLa cells overexpressing the A56 and K2 proteins to isolate adaptive mutant viruses. Genome sequencing of adaptive mutants revealed that they had accumulated a unique G9R open reading frame (ORF) mutation, resulting in a single His44Tyr amino acid change. We engineered a recombinant vaccinia virus to express the G9H44Y mutant protein, and it readily infected HeLa-A56/K2 cells. Moreover, similar to the ΔA56 virus, the G9H44Y mutant virus on HeLa cells had a cell fusion phenotype, indicating that G9H44Y-mediated membrane fusion was less prone to inhibition by A56/K2. Coimmunoprecipitation experiments demonstrated that the G9H44Y protein bound to A56/K2 at neutral pH, suggesting that the H44Y mutation did not eliminate the binding of G9 to A56/K2. Interestingly, upon acid treatment to inactivate A56/K2-mediated fusion inhibition, the G9H44Y mutant virus induced robust cell-cell fusion at pH 6, unlike the pH 4.7 required for control and revertant vaccinia viruses. Thus, A56/K2 fusion suppression mainly targets the G9 protein. Moreover, the G9H44Y mutant protein escapes A56/K2-mediated membrane fusion inhibition most likely because it mimics an acid-induced intermediate conformation more prone to membrane fusion.IMPORTANCE It remains unclear how the multiprotein entry fusion complex of vaccinia virus mediates membrane fusion. Moreover, vaccinia virus contains fusion suppressor proteins to prevent the aberrant activation of this multiprotein complex. Here, we used experimental evolution to identify adaptive mutant viruses that overcome membrane fusion inhibition mediated by the A56/K2 protein complex. We show that the H44Y mutation of the G9 protein is sufficient to overcome A56/K2-mediated membrane fusion inhibition. Treatment of virus-infected cells at different pHs indicated that the H44Y mutation lowers the threshold of fusion inhibition by A56/K2. Our study provides evidence that A56/K2 inhibits the viral fusion complex via the latter's G9 subcomponent. Although the G9H44Y mutant protein still binds to A56/K2 at neutral pH, it is less dependent on low pH for fusion activation, implying that it may adopt a subtle conformational change that mimics a structural intermediate induced by low pH.

Authors+Show Affiliations

Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China. Genome and Systems Biology Degree Program, Academia Sinica and National Taiwan University, Taipei, Taiwan, Republic of China.Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China.Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan, Republic of China mbwen@ccvax.sinica.edu.tw. Genome and Systems Biology Degree Program, Academia Sinica and National Taiwan University, Taipei, Taiwan, Republic of China.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

32132237

Citation

Hong, Guan-Ci, et al. "Experimental Evolution to Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition Via the Vaccinia Virus A56/K2 Protein Complex." Journal of Virology, vol. 94, no. 10, 2020.
Hong GC, Tsai CH, Chang W. Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex. J Virol. 2020;94(10).
Hong, G. C., Tsai, C. H., & Chang, W. (2020). Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex. Journal of Virology, 94(10). https://doi.org/10.1128/JVI.00093-20
Hong GC, Tsai CH, Chang W. Experimental Evolution to Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition Via the Vaccinia Virus A56/K2 Protein Complex. J Virol. 2020 May 4;94(10) PubMed PMID: 32132237.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Experimental Evolution To Isolate Vaccinia Virus Adaptive G9 Mutants That Overcome Membrane Fusion Inhibition via the Vaccinia Virus A56/K2 Protein Complex. AU - Hong,Guan-Ci, AU - Tsai,Chi-Hang, AU - Chang,Wen, Y1 - 2020/05/04/ PY - 2020/01/16/received PY - 2020/02/28/accepted PY - 2020/11/04/pmc-release PY - 2020/3/7/pubmed PY - 2020/3/7/medline PY - 2020/3/6/entrez KW - acid-dependent conformational change KW - experimental evolution KW - membrane fusion regulation KW - vaccinia virus A56 and K2 proteins KW - vaccinia virus G9 and A16 proteins KW - vaccinia virus entry fusion complex JF - Journal of virology JO - J. Virol. VL - 94 IS - 10 N2 - For cell entry, vaccinia virus requires fusion with the host membrane via a viral fusion complex of 11 proteins, but the mechanism remains unclear. It was shown previously that the viral proteins A56 and K2 are expressed on infected cells to prevent superinfection by extracellular vaccinia virus through binding to two components of the viral fusion complex (G9 and A16), thereby inhibiting membrane fusion. To investigate how the A56/K2 complex inhibits membrane fusion, we performed experimental evolutionary analyses by repeatedly passaging vaccinia virus in HeLa cells overexpressing the A56 and K2 proteins to isolate adaptive mutant viruses. Genome sequencing of adaptive mutants revealed that they had accumulated a unique G9R open reading frame (ORF) mutation, resulting in a single His44Tyr amino acid change. We engineered a recombinant vaccinia virus to express the G9H44Y mutant protein, and it readily infected HeLa-A56/K2 cells. Moreover, similar to the ΔA56 virus, the G9H44Y mutant virus on HeLa cells had a cell fusion phenotype, indicating that G9H44Y-mediated membrane fusion was less prone to inhibition by A56/K2. Coimmunoprecipitation experiments demonstrated that the G9H44Y protein bound to A56/K2 at neutral pH, suggesting that the H44Y mutation did not eliminate the binding of G9 to A56/K2. Interestingly, upon acid treatment to inactivate A56/K2-mediated fusion inhibition, the G9H44Y mutant virus induced robust cell-cell fusion at pH 6, unlike the pH 4.7 required for control and revertant vaccinia viruses. Thus, A56/K2 fusion suppression mainly targets the G9 protein. Moreover, the G9H44Y mutant protein escapes A56/K2-mediated membrane fusion inhibition most likely because it mimics an acid-induced intermediate conformation more prone to membrane fusion.IMPORTANCE It remains unclear how the multiprotein entry fusion complex of vaccinia virus mediates membrane fusion. Moreover, vaccinia virus contains fusion suppressor proteins to prevent the aberrant activation of this multiprotein complex. Here, we used experimental evolution to identify adaptive mutant viruses that overcome membrane fusion inhibition mediated by the A56/K2 protein complex. We show that the H44Y mutation of the G9 protein is sufficient to overcome A56/K2-mediated membrane fusion inhibition. Treatment of virus-infected cells at different pHs indicated that the H44Y mutation lowers the threshold of fusion inhibition by A56/K2. Our study provides evidence that A56/K2 inhibits the viral fusion complex via the latter's G9 subcomponent. Although the G9H44Y mutant protein still binds to A56/K2 at neutral pH, it is less dependent on low pH for fusion activation, implying that it may adopt a subtle conformational change that mimics a structural intermediate induced by low pH. SN - 1098-5514 UR - https://www.unboundmedicine.com/medline/citation/32132237/Experimental_Evolution_To_Isolate_Vaccinia_Virus_Adaptive_G9_Mutants_That_Overcome_Membrane_Fusion_Inhibition_via_the_Vaccinia_Virus_A56/K2_Protein_Complex L2 - http://jvi.asm.org/cgi/pmidlookup?view=long&pmid=32132237 DB - PRIME DP - Unbound Medicine ER -
Try the Free App:
Prime PubMed app for iOS iPhone iPad
Prime PubMed app for Android
Prime PubMed is provided
free to individuals by:
Unbound Medicine.